SKU(재고 관리 코드):LMG515Mu
Magnetic Luminex Assay Kit for Chymase 1, Mast Cell (CMA1) ,etc.
Magnetic Luminex Assay Kit for Chymase 1, Mast Cell (CMA1) ,etc.
Product No.
LMG515Mu
Organism Species
Mus musculus (Mouse).
Sample Type
Serum, plasma and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.78-800pg/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.26 pg/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Chymase 1, Mast Cell (CMA1) ,etc..
No significant cross-reactivity or interference between Chymase 1, Mast Cell (CMA1) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Chymase 1, Mast Cell (CMA1) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Chymase 1, Mast Cell (CMA1) ,etc. in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 78-97 | 90 |
EDTA plasma(n=5) | 99-105 | 102 |
heparin plasma(n=5) | 94-102 | 97 |
sodium citrate plasma(n=5) | 90-104 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Chymase 1, Mast Cell (CMA1) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Chymase 1, Mast Cell (CMA1) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Chymase 1, Mast Cell (CMA1) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 78-102% | 96-104% | 94-101% | 80-90% |
EDTA plasma(n=5) | 89-98% | 90-104% | 92-101% | 95-102% |
heparin plasma(n=5) | 81-104% | 81-92% | 91-103% | 83-96% |
sodium citrate plasma(n=5) | 94-105% | 98-105% | 95-103% | 93-103% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:CMA1) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Magazine | Citations |
Pathobiology | Anti-Angiotensin and Hypoglycemic Treatments Suppress Liver Metastasis of Colon Cancer Cells Karger: 000330169 |
Clinical and Experimental Metastasis | Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer PubMed: 22552372 |
Mediators of Inflammation | Mediators of Mast Cells in Bullous Pemphigoid and Dermatitis Herpetiformis Pubmed:25400334 |
Neurogastroenterology & Motility | Peritoneal mast cell degranulation and gastrointestinal recovery in patients undergoing colorectal surgery Pubmed:25677271 |
IJC Metab Endocr | The autocrine role of tryptase in pressure overload-induced mast cell activation, chymase release and cardiac fibrosis PubMed: 26722642 |
Journal of Neuroinflammation | Oral sensitization to whey proteins induces age-and sex-dependent behavioral abnormality and neuroinflammatory responses in a mouse model of food … Pubmed:29685134 |
Revista do Instituto de Medicina Tropical de São Paulo | Vasoactive intestinal peptide degradation might influence Interleukin-17 expression in cardiac chagasic patients Pubmed: 30365640 |
Science Advances | Platelets trigger perivascular mast cell degranulation to cause inflammatory responses and tissue injury Pubmed: 32206714 |
Immunity Inflammation and Disease | Disruption in the balance between apolipoprotein A‐I and mast cell chymase in chronic hypersensitivity pneumonitis Pubmed: 33016012 |
Microbiol Spectr | Mast Cell-Derived Proteases Induce Endothelial Permeability and Vascular Damage in Severe Fever with Thrombocytopenia Syndrome Pubmed:35612327 |
Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
RPG515Mu01 | Recombinant Chymase 1, Mast Cell (CMA1) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAG515Mu01 | Polyclonal Antibody to Chymase 1, Mast Cell (CMA1) | WB,IHC |
PAG515Mu02 | Polyclonal Antibody to Chymase 1, Mast Cell (CMA1) | WB; IHC; ICC; IP. |
LAG515Mu81 | FITC-Linked Polyclonal Antibody to Chymase 1, Mast Cell (CMA1) | WB; IHC; ICC; IF. |
LAG515Mu71 | Biotin-Linked Polyclonal Antibody to Chymase 1, Mast Cell (CMA1) | WB; IHC; ICC. |
SEG515Mu | ELISA Kit for Chymase 1, Mast Cell (CMA1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMG515Mu | Magnetic Luminex Assay Kit for Chymase 1, Mast Cell (CMA1) ,etc. | Magnetic Luminex Assay for Antigen Detection. |